Minireviews
Copyright ©The Author(s) 2015.
World J Stem Cells. Aug 26, 2015; 7(7): 1039-1046
Published online Aug 26, 2015. doi: 10.4252/wjsc.v7.i7.1039
Table 1 High dose therapy followed by autologous stem cell transplantation in Hodgkin lymphoma
Ref.YearPatients (n)Status of HLRegimenTRM (%)PFS (%)OS (%)Follow-up (mo)
Ramzi et al[5]201245R/RCEAM2.2778424
Czyz et al[6]2013132R/RModified BEAM-667668
Shafey et al[7]201273R/RDICEP1618056
Sinha et al[9]201330R/RVTEPA0678132
Di Ianni et al[10]201258R/RTECA0728260
Table 2 High dose therapy followed by autologous stem cell transplantation in non-Hodgkin lymphoma
Ref.YearPatients (n)DiseaseRegimenTRM (%)ORR (%)OS (%)Follow-up (mo)
Kim et al[11]201244Chemosensitive-NHLNEAM2.9796424
Falzetti et al[12]201245HR NHLTT-Vp-Car4.4777160
William et al[13]201442R/R NHLV-BEAM0879112
Visani et al[14]201143R/R HL and NHLBeEAM0828118
Visani et al[15]201443R/R HL and NHLBeEAM0728841
Isidori et al[16]201437R/R NHLBeEAM2.788949
Musso et al[17]201084R/R HL and NHLFEAM2.4738813
Kruger et al[19]201216R/R NHLRIT + BEAM6947544
Winter et al[20]200944R/R NHLZ-BEAM2.2776033
Shimoni et al[21]201243R/R NHLZ-BEAM0979124
Briones et al[22]201430R/R NHLRIT + BEAM3.5706331